reninangiotensin
system
ra
power
biolog
system
play
import
role
regul
system
blood
pressur
mainten
fluid
salt
homeostasi
multifactori
system
sinc
includ
differ
compon
fig
first
renin
discov
wherea
discoveri
last
compon
angiotensinconvert
enzym
ace
rel
recent
three
kind
ra
known
circul
b
local
c
intracellular
circul
ra
act
system
level
substrat
angiotensinogen
releas
liver
cleav
form
angiotensin
angi
renin
enzym
secret
juxtaglomerular
cell
kidney
main
effector
peptid
system
angiotensin
ii
angii
gener
angi
ace
act
power
vasoconstrictor
b
local
tissu
rass
describ
sever
organ
tissu
synthes
angii
local
sinc
possess
whole
ra
enzymat
machineri
c
recent
studi
reveal
intracellular
complet
ra
produc
angii
ra
therefor
consid
endocrin
paracrin
intracrin
system
endothelium
continu
layer
simpl
squamou
epitheli
cell
endotheli
cell
contribut
system
homeostasi
differ
function
barrier
mainten
coagul
thrombolyt
process
particip
immun
reaction
synthesi
differ
vasoact
compound
direct
injuri
mechan
chemic
infect
endothelium
expos
basement
membran
compon
blood
lead
seri
event
call
inflammatori
cascad
includ
alter
vascular
integr
product
releas
cytokin
adhes
molecul
procoagul
agent
reactiv
oxygen
speci
ro
addit
wellknown
regulatori
role
hemodynam
homeostasi
ra
particular
angii
fig
also
involv
modul
inflammatori
process
inde
angii
regul
vascular
permeabl
first
step
inflammatori
respons
induc
synthesi
prostaglandin
vascular
endotheli
cell
growth
factor
vegf
moreov
ra
particip
leukocyt
extravas
critic
step
inflammatori
respons
differ
level
angii
activ
leukocyt
increas
adhes
endotheli
cell
via
induct
proinflammatori
mediat
like
selectin
adhes
molecul
chemokin
cytokin
factor
eg
transform
growth
factor
tgf
angii
effect
mediat
receptor
angiotensin
receptor
lead
activ
transcript
factor
includ
activ
nuclear
ensu
express
gene
involv
inflamm
tissu
injuri
patient
cardiovascular
diseas
increas
selectin
express
plasma
chemokin
level
attenu
treatment
losartan
antagonist
experiment
studi
demonstr
angii
infus
dosag
unabl
induc
vasoconstrict
increas
leukocyt
transmigr
treatment
angiotensin
receptor
antagonist
suppress
leukocyt
respons
final
ra
particip
last
phase
inflamm
cell
growth
tissu
repair
preclin
studi
kidney
reveal
angii
induc
cellular
growth
releas
sever
growth
factor
result
organ
hypertrophi
massiv
matrix
synthesi
format
scar
studi
demonstr
angii
also
induc
fibrosi
tissu
heart
lung
well
known
ra
involv
pathophysiolog
sever
diseas
occur
differ
organ
eg
heart
kidney
overactiv
ra
link
develop
atherosclerosi
hypertens
cardio
vascular
renal
event
myocardi
infarct
stroke
congest
heart
failur
diabet
nephrosclerosi
tumorigenesi
sever
studi
focus
lung
diseas
pulmonari
hypertens
pulmonari
fibrosi
order
better
understand
role
ra
field
capillari
lung
one
main
site
ace
express
therebi
lung
consid
import
sourc
angii
pulmonari
hypertens
character
increas
vascular
resist
endotheli
remodel
eventu
lead
right
heart
failur
death
context
angii
seem
mediat
proinflammatori
signal
rather
vasoconstrict
result
pulmonari
vascular
remodel
inde
angii
induc
smooth
muscl
cell
prolifer
consequ
increas
pulmonari
arteri
wall
thick
evid
demonstr
involv
ra
pathophysiolog
pulmonari
fibrosi
angii
upregul
express
thu
differenti
fibroblast
myofibroblast
increas
extracellular
matrix
deposit
well
alveolar
epitheli
cell
apoptosi
among
variou
scenario
ra
role
chapter
focus
current
knowledg
role
ra
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
fig
ace
key
enzym
ra
highli
express
lung
endotheli
cell
repres
ectoenzym
uniformli
distribut
along
lumin
surfac
catalyt
site
expos
bloodborn
substrat
clinic
data
seem
indic
ace
activ
relat
ali
pathogenesi
outcom
idel
et
al
found
ace
level
augment
bronchoalveolar
lavag
bal
fluid
ard
patient
compar
normal
subject
patient
affect
sarcoidosi
fibrosi
particular
ace
level
highest
bal
fluid
patient
ard
infecti
origin
author
specul
ace
bal
fluid
could
marker
endotheli
damag
two
year
earlier
fourrier
et
al
perform
sequenti
measur
ace
level
serum
patient
ard
sepsi
without
ard
found
ard
survivor
ace
level
biphas
evolut
decreas
earli
phase
ill
increas
time
wean
convers
ace
level
ard
nonsurvivor
decreas
earli
phase
without
later
increas
final
patient
sepsi
without
ard
level
ace
remain
elev
author
postul
low
level
circul
ace
index
pulmonari
endotheli
injuri
correl
presenc
sever
ard
ard
appear
rel
low
incid
compar
number
subject
potenti
risk
develop
syndrom
thu
genet
background
predispos
ill
postul
ace
gene
locat
chromosom
contain
restrict
fragment
length
polymorph
consist
insert
delet
alu
repeat
sequenc
intron
delet
alu
sequenc
associ
greater
ace
activ
plasma
peripher
blood
mononuclear
cell
marshal
et
al
perform
retrospect
studi
compar
patient
ard
patient
nonard
respiratori
failur
found
delet
alu
sequenc
ace
gene
associ
higher
incid
ard
increas
mortal
ard
group
suggest
increas
ace
activ
correl
risk
outcom
ard
differ
result
obtain
orfano
et
al
order
assess
whether
pulmonari
capillari
endothelium
bound
pceb
ace
activ
could
marker
endotheli
injuri
thu
predict
develop
sever
ali
patient
group
accord
lung
injuri
score
li
pcebac
activ
measur
author
observ
pcebac
activ
decreas
patient
aliard
compar
nonard
patient
invers
correl
li
apach
ii
score
data
suggest
pcebac
dysfunct
earli
marker
presenc
sever
endotheli
cell
damag
fact
delet
alu
sequenc
lead
higher
activ
ace
relat
pathogenesi
ard
appear
contrast
fact
pcebac
activ
reduc
consequ
pulmonari
endotheli
dysfunct
maniati
et
al
interpret
paradox
infer
increas
ace
angii
activ
could
gener
superoxid
anion
interact
ro
nitric
oxid
lead
synthesi
reactiv
nitrogen
speci
damag
pulmonari
endothelium
consequ
reduct
ace
activ
counterbal
proinflammatori
activ
anoth
hypothesi
crude
loss
endothelium
result
reduc
pcebac
activ
wherea
normal
even
normal
activ
healthi
zone
lung
main
biolog
activ
ace
cleavag
angi
give
angii
thu
appear
main
effector
ace
respons
ard
pathogenesi
angii
octapeptid
sever
biolog
activ
mani
alreadi
describ
review
action
mediat
two
differ
receptor
show
opposit
biolog
effect
fig
role
angii
pathogenesi
aliard
seem
strongli
link
proinflammatori
properti
kuba
et
al
show
murin
model
ali
caus
acid
aspir
inject
sever
acut
respiratori
syndrom
sar
coronaviru
spike
protein
level
angii
lung
increas
degre
increas
proport
degre
lung
injuri
assess
histopatholog
angii
level
significantli
higher
lung
mice
subject
doubl
injuri
acid
aspir
viral
infect
howev
pulmonari
edema
hallmark
aliard
due
increas
hydrostat
pressur
typic
effect
angii
augment
system
pressur
may
promot
pulmonari
edema
enhanc
permeabl
studi
demonstr
local
angii
abl
act
directli
vascular
permeabl
stimul
vegf
prostaglandin
thu
exert
primarili
proinflammatori
effect
mediat
hemodynam
alter
yield
import
evid
assess
role
angii
pathogenesi
aliard
group
demonstr
receptor
implic
angii
action
develop
ali
inhibit
attenu
ali
shown
increas
complianc
attenu
pulmonari
edema
ang
ii
may
also
play
role
regul
apoptosi
type
ii
pneumocyt
import
phenomenon
late
phase
ard
fact
prolifer
type
ii
pneumocyt
characterist
earli
phase
ali
repar
phenomenon
apoptosi
indic
evolut
toward
fibrot
role
reninangiotensin
system
ard
v
phase
diseas
angii
seem
promot
apoptosi
modul
fasfa
ligand
system
bear
major
implic
pathogenesi
evolut
ali
apoptosi
alveolar
epitheli
cell
wang
et
al
confirm
role
angii
modul
apoptosi
alveolar
epitheli
cell
cultur
medium
supplement
differ
dose
angii
angiotensinogen
protein
abl
induc
apoptosi
alveolar
epitheli
cell
concentrationdepend
manner
moreov
author
observ
nonselect
angiotensin
receptor
antagonist
saralasin
could
inhibit
apoptosi
induc
protein
lisinopril
aceinhibitor
block
apoptosi
induc
angiotensinogen
angii
data
show
relationship
angii
alveolar
epitheli
cell
apoptosi
although
alveolar
epitheli
cell
express
mrna
angii
receptor
select
inhibit
block
apoptosi
caus
angii
find
marshal
et
al
show
angii
could
influenc
progress
ali
toward
fibrot
diseas
angii
mitogen
human
adult
fibroblast
via
receptor
stimul
autocrin
releas
profibrot
cytokin
procollagen
product
fetal
lung
fibroblast
final
rat
model
pulmonari
fibrosi
bleomycin
augment
lung
angii
concentr
wherea
treatment
ace
inhibitor
inhibitor
abl
attenu
lung
collagen
accumul
express
sever
anim
model
help
disclos
relationship
lipopolysaccharid
lp
induc
ali
angii
mainli
use
select
inhibitor
receptor
first
sepsisinduc
ali
character
increas
level
angii
lung
tissu
treatment
inhibitor
led
improv
permeabl
index
vivo
wetdri
weight
ratio
quantif
evan
blue
dye
extravas
histolog
evid
edema
vitro
studi
support
data
sinc
monolay
rat
pulmonari
microvascular
endotheli
cell
increas
permeabl
follow
exposur
angii
increas
permeabl
partial
correct
ad
inhibitor
cultur
medium
role
angii
inflammatori
cascad
endotheli
dysfunct
demonstr
cytokin
level
sepsi
induc
secret
sever
proinflammatori
cytokin
lung
plasma
includ
tumor
necrosi
factor
tnf
interleukin
il
secret
partial
inhibit
infus
inhibitor
two
group
perform
addit
studi
understand
mechan
underli
angii
proinflammatori
action
group
found
inhibit
led
lesser
activ
pathway
mediat
increas
level
inhibitor
signal
transduct
mitogenactiv
protein
kinas
mapk
cascad
cjun
ntermin
kinas
jnk
seem
also
involv
proinflammatori
effect
angii
first
human
homolog
ace
discov
two
independ
group
human
express
endothelium
predominantli
heart
kidney
testi
although
express
also
distribut
lung
liver
small
intestin
brain
human
consist
amino
acid
type
integr
membran
glycoprotein
extracellular
domain
contain
potenti
metalloproteas
zinc
bind
site
singl
transmembran
domain
cytoplasm
tail
one
catalyt
domain
show
ident
amino
domain
ace
carboxypeptidas
sinc
cleav
one
ctermin
residu
substrat
rather
dipeptid
ace
fig
particular
differ
two
enzym
make
resist
action
ace
inhibitor
sinc
mimic
dipeptidyl
ctermin
bind
site
ace
substrat
convert
angi
ang
angii
ang
ang
convert
ace
ang
rice
colleagu
demonstr
hydrolyz
angii
effici
angi
therefor
product
ang
power
vasodil
believ
primari
goal
activ
ang
discuss
depth
later
chapter
moreov
vasoact
peptid
substrat
catalyt
activ
neurotensin
kinetensin
desarg
bradykinin
present
lung
healthi
diseas
human
express
type
type
ii
alveolar
epitheli
cell
bronchiolar
epitheli
cell
may
play
import
role
ali
shown
experiment
studi
imai
et
al
examin
extens
protect
sever
acut
lung
failur
two
murin
model
ali
acid
aspir
sepsi
loss
knockout
mice
result
decreas
complianc
pulmonari
edema
leukocyt
infiltr
anim
model
pulmonari
edema
seem
predominantli
due
alter
vascular
permeabl
demonstr
evan
blue
accumul
rather
hemodynam
caus
inde
differ
heart
contractil
pulmonari
vascular
tone
found
although
author
exclud
potenti
effect
angii
blood
vessel
underlin
protect
action
counterbal
ace
function
imai
et
al
demonstr
ace
angii
promot
ali
differ
type
knockout
mice
wherea
protect
neg
regul
angii
level
lack
increas
lung
plasma
appear
play
role
also
pathogenesi
sar
consid
sar
viru
receptor
interact
viru
lead
endocytosi
viral
particl
viral
fusion
cell
absenc
knockout
mice
result
dramat
reduct
sarscoronaviru
infect
subsequ
reduc
histolog
alter
leukocyt
infiltr
kuba
et
al
demonstr
vivo
mechan
underli
elev
sever
mortal
viral
infect
sarscoronaviru
infect
downregul
express
sar
infect
protect
arm
ra
impair
loss
abil
neg
regul
angii
level
significantli
increas
lung
tissu
author
demonstr
inhibit
thu
inhibit
angii
activ
attenu
sever
lung
injuri
term
lung
mechan
properti
pulmonari
edema
sarscoronaviru
challeng
mice
ang
biolog
activ
heptapeptid
fig
releas
angi
angii
differ
peptidas
one
import
ang
exert
action
via
receptor
ma
orphan
g
proteincoupl
receptor
although
also
bind
affin
modest
compar
angii
ma
arm
consid
v
ere
princip
counterregulatori
mechan
ra
arm
inde
two
arm
system
act
opposit
way
first
lead
format
ang
simultan
decreas
angii
second
form
power
vasoconstrictor
angii
catabol
ang
bradykinin
ang
substrat
inhibitor
ace
sinc
cleav
ndomain
ace
form
ang
also
inhibit
function
ace
cdomain
ang
act
vasodil
inhibit
ace
addit
releas
achiev
indirect
potenti
bradykinin
addit
vasodilatori
properti
ang
interact
receptor
ma
exert
antiprolif
effect
vascular
smooth
muscl
cell
fibromuscular
tissu
lung
cancer
cell
moreov
reduc
organ
remodel
limit
hypertrophi
collagen
deposit
thu
fibrosi
subsequ
improv
organ
function
recent
studi
experiment
model
arthriti
show
antiinflammatori
effect
ang
ma
receptor
activ
ma
use
ma
agonist
decreas
releas
cytokin
roll
adhes
leukocyt
endothelium
injur
site
also
decreas
histolog
abnorm
classic
sign
inflamm
pain
edema
author
suggest
ma
receptor
agonist
may
novel
therapeut
approach
treatment
arthriti
human
limit
inform
avail
concern
role
ang
receptor
healthi
diseas
lung
uhal
et
al
recent
demonstr
protect
effect
ang
alveolar
epitheli
cell
surviv
via
masmedi
inhibit
apoptosi
fact
ang
inhibit
jnk
phosphoryl
caspas
activ
nuclear
fragment
act
ma
receptor
blockad
convers
favor
apoptosi
previous
review
data
show
ra
role
aliard
pathogenesi
reason
sever
experiment
studi
perform
evalu
therapeut
role
ra
modul
set
exampl
hagiwara
et
al
develop
model
lpsinduc
ali
rat
show
therapi
ace
inhibitor
could
diminish
interstiti
edema
alveolar
cellular
infiltr
cytokin
releas
probabl
via
reduct
ang
ii
level
inhibit
pathway
differ
model
ali
induc
associ
chronic
ethanol
ingest
endotoxemia
alveolar
epitheli
permeabl
improv
therapi
lisinopril
losartan
drug
abl
reduc
level
lung
tissu
avoid
glutathion
deplet
thu
limit
epitheli
dysfunct
oxid
stress
final
experiment
model
oleic
acidinduc
ali
confirm
captopril
could
attenu
pulmonari
injuri
protect
vascular
endothelium
number
circul
endotheli
cell
captopriltr
group
reduc
compar
control
group
addit
decreas
express
intercellular
adhes
molecul
icam
activ
pathway
captopril
treat
rat
also
better
pao
fio
ratio
less
edema
clinic
trial
perform
investig
effect
ra
modul
ard
patient
howev
retrospect
cohort
studi
v
zambelli
grassi
g
bellani
v
duct
assess
effect
surviv
prior
use
ace
inhibitor
patient
hospit
commun
acquir
pneumonia
prior
use
ace
inhibitor
associ
lower
mortal
far
ma
arm
concern
antiinflammatori
properti
propos
therapi
aliard
inject
recombin
human
knockout
mice
rescu
phenotyp
decreas
sever
ali
improv
aliard
symptom
wild
type
mice
suggest
administr
may
novel
potenti
therapeut
strategi
ard
studi
evalu
therapeut
potenti
anim
model
lpsinduc
lung
injuri
show
treatment
reduc
plasma
angii
level
improv
inflammatori
respons
pulmonari
edema
control
anim
receiv
lp
infus
develop
pulmonari
hypertens
wherea
treatment
group
mean
pulmonari
arteri
pressur
reduc
without
chang
pulmonari
arteri
occlus
pressur
indic
pulmonari
vasodilatori
function
addit
treatment
improv
lpsinduc
arteri
hypoxemia
probabl
homogen
perfus
treat
anim
chapter
review
main
evid
concern
role
ra
compon
aliard
addit
well
known
cardiovascular
renal
regulatori
properti
ra
particip
differ
phase
inflamm
releas
cytokin
extravas
leukocyt
matrix
deposit
tissu
repair
aliard
character
power
inflammatori
respons
persist
time
attempt
repair
injuri
result
format
scar
tissu
although
ra
modul
appear
promis
therapeut
strategi
data
need
collect
elucid
whether
would
feasibl
clinic
effect
mean
attenu
lung
injuri
enhanc
effect
recent
discov
arm
may
potenti
strategi
decreas
deleteri
effect
angii
